These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Anticoagulant therapy and its indications in cardiovascular diseases]. DONZELOT E; KAUFMANN H Rev Prat; 1953 Dec; 3(33):2483-92. PubMed ID: 13135189 [No Abstract] [Full Text] [Related]
7. [The value of a rapidly acting anticoagulant in cardiovascular diseases]. SEISLER KH Ther Ggw; 1959 Jun; 98(6):281-5. PubMed ID: 13676099 [No Abstract] [Full Text] [Related]
8. [The initial experience of using fraxiparin in extracorporeal detoxication in clinical cardiology]. Sirenko IuN; Sychev OS; Reĭko MN; Shchupak MB; Sidorenko PI Klin Khir (1962); 1994; (12):23-5. PubMed ID: 9173120 [TBL] [Abstract][Full Text] [Related]
9. [Heparin in peripheral circulatory disorders]. LIPS AC; de SONNAVILLE L Ned Tijdschr Geneeskd; 1953 Jun; 97(23):1448-56. PubMed ID: 13087389 [No Abstract] [Full Text] [Related]
10. Depo-heparin for long term therapy of myocardial infarction. SUSSMAN I; LYDECKER E J Med Soc N J; 1952 Aug; 49(8):344-6. PubMed ID: 12981518 [No Abstract] [Full Text] [Related]
11. [Heparin and ischemic stroke]. Tessitore A; Di Marco O; Mugnano AM Acta Neurol (Napoli); 1993 Jun; 15(3):222-31. PubMed ID: 8237522 [TBL] [Abstract][Full Text] [Related]
12. [Surgery under heparin. II. Place of heparin in prevention of postoperative hemorrhage (91 cases)]. Baille Y; Monties JR; Blanc T; Goudard A; Jaquenoud P; Henry E Agressologie; 1968; 9(6):717-24. PubMed ID: 5729133 [No Abstract] [Full Text] [Related]
13. [Anticoagulants in cardiovascular diseases]. MAYALL R Rev Bras Med; 1953 Feb; 10(2):109-11. PubMed ID: 13074757 [No Abstract] [Full Text] [Related]
14. Myocardial infarction; comparison of results following use of dicumarol and dicumarol with heparin in the acute stage. BOLT RJ J Mich State Med Soc; 1953 Jan; 52(1):65-8; passim. PubMed ID: 13023390 [No Abstract] [Full Text] [Related]
16. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators. Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712 [TBL] [Abstract][Full Text] [Related]
17. Heparin-polynitroxide derivatives: a platform for new diagnostic and therapeutic agents in cardiovascular disease? Kleschyov AL; Sen' VD Future Med Chem; 2013 Mar; 5(4):385-8. PubMed ID: 23495686 [No Abstract] [Full Text] [Related]
18. [A new fast-acting anticoagulant in the treatment of circulation disorders, embolisms and thromboses]. MEHL H Med Klin; 1958 Oct; 53(44):1911-2. PubMed ID: 13612671 [No Abstract] [Full Text] [Related]
19. Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease. Blessing F; Wang Y; Walli AK; Seidel D Transfus Apher Sci; 2004 Jun; 30(3):255-66. PubMed ID: 15172631 [TBL] [Abstract][Full Text] [Related]